SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported) May 9, 2007
BARR PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
(State or other jurisdiction
of incorporation)
|
|
1-9860
(Commission
File Number)
|
|
42-1612474
(IRS Employer
Identification No.) |
|
|
|
400 Chestnut Ridge Road, Woodcliff Lake, NJ
(Address of principal executive offices)
|
|
07677
(Zip code) |
(201) 930-3300
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
|
|
|
o
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
o
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
o
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b)) |
|
|
|
o
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c)) |
Item 2.02 Results of Operations and Financial Condition.
On May 9, 2007, Barr Pharmaceuticals, Inc. (the Company) issued a press
release announcing results for the three months ended March 31, 2007. A copy of
the release is being furnished as Exhibit 99.1 to this Current Report on Form
8-K and is incorporated herein by reference. The information furnished in this
Item 2.02 and in Exhibit 99.1 below shall not be deemed filed for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be
deemed incorporated by reference in any filing with the Securities and Exchange
Commission.
The Company will host a Conference Call at 8:30 AM Eastern time on
Wednesday, May 9, 2007 to discuss these results. The number to call from within
the United States is (800) 230-1085, and those outside the United States should
call (612) 338-1040. A replay of the conference call will be available from 12
Noon Eastern time on May 9, 2007 through 11:59 PM Eastern time on May 16, 2007,
and can be accessed by dialing (800) 475-6701 in the United States and (320)
365-3844 from outside the United States, and using the access code 870116.
The conference call will also be webcast live on the Internet. Investors
and other interested parties may access the live webcast through the Investors
section, under Calendar of Events, on Barrs website at
www.barrlabs.com. Log
on at least 15 minutes before the call begins to register and download or
install any necessary audio software.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits:
99.1
Barr Pharmaceuticals, Inc. May 9, 2007 earnings release